Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

How to Get Rebif Covered by UnitedHealthcare in Washington: Complete PA Guide with Appeal Scripts

Answer Box: Fastest Path to Rebif Approval To get Rebif (interferon beta-1a) covered by UnitedHealthcare in Washington: Submit prior authorization through OptumRx with MS diagnosis confirmation (McDonald 2017 criteria), recent brain MRI showing lesions, baseline CBC/liver function tests, and documentation of any failed alternative DMTs. If denied, file internal

The Requirements Checklist to Get Fintepla (fenfluramine) Covered by UnitedHealthcare in New York: Forms, Appeals, and REMS Documentation

Answer Box: Getting Fintepla Covered by UnitedHealthcare in New York To get Fintepla (fenfluramine) covered by UnitedHealthcare in New York: First, enroll in the mandatory Fintepla REMS program and complete baseline echocardiography. Then submit prior authorization through UnitedHealthcare's provider portal with diagnosis confirmation (ICD-10 G40.83 for Dravet

UnitedHealthcare's Coverage Criteria for Koselugo (Selumetinib) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Getting Koselugo Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Koselugo (selumetinib) under both medical and pharmacy benefits, with no step therapy requirements for pediatric NF1 plexiform neurofibromas. Medical necessity requires confirmed NF1 diagnosis with symptomatic, inoperable plexiform neurofibromas, baseline LVEF assessment, and ophthalmologic evaluation.

How to Get Eloctate Covered by UnitedHealthcare in Michigan: Prior Authorization Guide and State Appeal Rights

Answer Box: To get Eloctate covered by UnitedHealthcare in Michigan, you need prior authorization through OptumRx specialty pharmacy network. Start with your hematologist submitting PA documentation including factor VIII levels, bleeding history, and any prior therapy failures. If denied, Michigan's Patient's Right to Independent Review Act

How to Get Rezlidhia (olutasidenib) Covered by UnitedHealthcare in Ohio: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Rezlidhia Covered in Ohio Rezlidhia (olutasidenib) requires prior authorization through UnitedHealthcare's OptumRx. Submit your PA request online via the UnitedHealthcare Provider Portal with IDH1 mutation confirmation, AML diagnosis, and treatment history. If denied, you have 180 days for internal appeals, then external review through Ohio&

If Berinert Isn't Approved by UnitedHealthcare in Ohio: Formulary Alternatives & Exception Paths

Answer Box: Getting HAE Treatment When Berinert Is Denied If UnitedHealthcare denies Berinert (C1-esterase inhibitor, IV) in Ohio, you have three main options: try preferred formulary alternatives like Orladeyo (oral prophylaxis) or Ekterly (oral on-demand), request a drug list exception with strong medical necessity documentation, or appeal the denial through

Renewing Lumizyme (Alglucosidase Alfa) Coverage with UnitedHealthcare in Washington: Annual Documentation Requirements and Timeline

Answer Box: Renewing Lumizyme Coverage with UnitedHealthcare in Washington UnitedHealthcare requires annual prior authorization renewal for Lumizyme (alglucosidase alfa) with documentation of continued clinical response. Start the renewal process 30-60 days before your current authorization expires. Submit updated pulmonary function tests, 6-Minute Walk Test results, and specialist notes showing stable

UnitedHealthcare's Coverage Criteria for Helixate (Antihemophilic Factor rFVIII) in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Helixate Covered by UnitedHealthcare in Texas Important Update: Helixate and related products (Kogenate FS) were discontinued in the US by 2023. UnitedHealthcare now requires prior authorization for alternative rFVIII products like Kovaltry, Jivi, or Advate for hemophilia A treatment. Fastest Path to Coverage: 1. Have your hematologist

Renewing Xembify Approval with UnitedHealthcare in Michigan: 2025 Requirements, Timeline, and Appeal Process

Quick Answer: Renewing Xembify with UnitedHealthcare in Michigan Start your Xembify renewal 60-90 days before expiration to avoid treatment interruptions. UnitedHealthcare requires annual prior authorization renewal through OptumRx, typically processed within 3-5 business days for standard requests. Submit updated clinical documentation including recent IgG trough levels (within 90 days), infection

Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in Pennsylvania: Clinical Trial Access and Compassionate Use Appeals Guide

Answer Box: Your Fastest Path to Zanzalintinib Coverage Getting Zanzalintinib (XL092) covered by UnitedHealthcare in Pennsylvania requires clinical trial enrollment or compassionate use approval, since this investigational TKI has no FDA approval. Your three options: (1) Enroll in an active STELLAR program trial where UnitedHealthcare covers routine monitoring costs, (2)